Reply to correspondence on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
| Published in: | Clinical and Molecular Hepatology |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
Korean Association for the Study of the Liver
2025-01-01
|
| Subjects: | |
| Online Access: | http://e-cmh.org/upload/pdf/cmh-2024-0886.pdf |